...
首页> 外文期刊>Journal of Medicinal Chemistry >Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo
【24h】

Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo

机译:关于4-喹诺酮-3-羧酸基序的研究。 2.具有体内止痛作用的强效和选择性大麻素2受体激动剂的合成及其构效关系

获取原文
获取原文并翻译 | 示例

摘要

Quinolone-3-carboxamides 11 bearing at position 5, 6, 7, or 8 diverse substituents such as halides, alkyl, aryl, alkoxy, and aryloxy groups differing in their steric/electronic properties, were prepared. The new compounds were tested in vitro for CB1 and CB2 receptor affinity in comparison with the reference compounds rimonabant and SR144528. The tested compounds exhibited CB2 affinity in the ran, e from 55.9 to 0.8 nM and CB1 affinity in the range from > 10 000 to 5.3 nM, with selectivity indeces [K-i(CB1)/K-i(CB2)] varying from > 2666.6 to 1.23. On the basis of the structure-selectivity relationship developed, the presence of a substituent at C6/C8 or C7 well accounts for the high or low CB2 selectivity, respectively. Compound 11c, characterized by high CB2 affinity and selectivity, showed analgesic activity in the formalin test of acute peripheral and inflammatory pain in mice as a result of selective CB2 agonistic activity.
机译:制备了在位置5、6、7或8处带有不同取代基的喹诺酮-3-羧酰胺11,所述取代基诸如其空间/电子性质不同的卤化物,烷基,芳基,烷氧基和芳氧基。与参考化合物利莫那班和SR144528相比,在体外测试了新化合物的CB1和CB2受体亲和力。被测化合物在运行中表现出CB2亲和力,e从55.9至0.8 nM,CB1亲和力在> 10000至5.3 nM的范围内,选择性降低[Ki(CB1)/ Ki(CB2)]从> 2666.6至1.23不等。根据所发展的结构-选择性关系,在C6 / C8或C7处存在取代基分别说明了高或低CB2选择性。具有高CB2亲和力和选择性的特征的化合物11c由于选择性的CB2激动活性,在福尔马林试验中在小鼠急性周围和炎性疼痛中显示出止痛活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号